vs
Side-by-side financial comparison of Intuitive Surgical (ISRG) and T. Rowe Price (TROW). Click either name above to swap in a different company.
Intuitive Surgical is the larger business by last-quarter revenue ($2.8B vs $1.9B, roughly 1.5× T. Rowe Price). Intuitive Surgical runs the higher net margin — 29.8% vs 26.1%, a 3.7% gap on every dollar of revenue. On growth, Intuitive Surgical posted the faster year-over-year revenue change (23.0% vs -4.0%). Over the past eight quarters, Intuitive Surgical's revenue compounded faster (17.4% CAGR vs 3.5%).
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S.
T. Rowe Price Group, Inc. is an American publicly owned global investment management firm that offers funds, subadvisory services, separate account management, and retirement plans and services for individuals, institutions, and financial intermediaries. The firm has assets under management of more than $1.51 trillion and annual revenues of $6.48 billion as of 2023, placing it 537 on the Fortune 1000 list of the largest U.S. companies.
ISRG vs TROW — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.8B | $1.9B |
| Net Profit | $826.0M | $484.1M |
| Gross Margin | 66.1% | — |
| Operating Margin | 64.8% | 36.6% |
| Net Margin | 29.8% | 26.1% |
| Revenue YoY | 23.0% | -4.0% |
| Net Profit YoY | 17.4% | 2.7% |
| EPS (diluted) | $2.28 | $2.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.8B | $1.9B | ||
| Q4 25 | $2.9B | $1.9B | ||
| Q3 25 | $2.5B | $1.9B | ||
| Q2 25 | $2.4B | $1.7B | ||
| Q1 25 | $2.3B | $1.8B | ||
| Q4 24 | $2.4B | $1.8B | ||
| Q3 24 | $2.0B | $1.8B | ||
| Q2 24 | $2.0B | $1.7B |
| Q1 26 | $826.0M | $484.1M | ||
| Q4 25 | $794.8M | $445.3M | ||
| Q3 25 | $704.4M | $646.1M | ||
| Q2 25 | $658.4M | $505.2M | ||
| Q1 25 | $698.4M | $490.5M | ||
| Q4 24 | $685.7M | $439.9M | ||
| Q3 24 | $565.1M | $603.0M | ||
| Q2 24 | $526.9M | $483.4M |
| Q1 26 | 66.1% | — | ||
| Q4 25 | 66.4% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 66.3% | — | ||
| Q1 25 | 64.7% | — | ||
| Q4 24 | 68.0% | — | ||
| Q3 24 | 67.4% | — | ||
| Q2 24 | 68.3% | — |
| Q1 26 | 64.8% | 36.6% | ||
| Q4 25 | 30.2% | 24.4% | ||
| Q3 25 | 30.3% | 34.0% | ||
| Q2 25 | 30.5% | 27.8% | ||
| Q1 25 | 25.7% | 33.8% | ||
| Q4 24 | 30.4% | 31.2% | ||
| Q3 24 | 28.3% | 34.4% | ||
| Q2 24 | 28.2% | 32.6% |
| Q1 26 | 29.8% | 26.1% | ||
| Q4 25 | 27.7% | 23.0% | ||
| Q3 25 | 28.1% | 34.1% | ||
| Q2 25 | 27.0% | 29.3% | ||
| Q1 25 | 31.0% | 27.8% | ||
| Q4 24 | 28.4% | 24.1% | ||
| Q3 24 | 27.7% | 33.8% | ||
| Q2 24 | 26.2% | 27.9% |
| Q1 26 | $2.28 | $2.23 | ||
| Q4 25 | $2.19 | $1.98 | ||
| Q3 25 | $1.95 | $2.87 | ||
| Q2 25 | $1.81 | $2.24 | ||
| Q1 25 | $1.92 | $2.15 | ||
| Q4 24 | $1.89 | $1.91 | ||
| Q3 24 | $1.56 | $2.64 | ||
| Q2 24 | $1.46 | $2.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $3.7B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.6B | $974.7M |
| Total Assets | $20.1B | $14.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $3.7B | ||
| Q4 25 | $5.9B | $3.4B | ||
| Q3 25 | $4.9B | $3.6B | ||
| Q2 25 | $5.3B | $3.1B | ||
| Q1 25 | $4.5B | $2.8B | ||
| Q4 24 | $4.0B | $2.6B | ||
| Q3 24 | $4.2B | $3.2B | ||
| Q2 24 | $4.8B | $2.7B |
| Q1 26 | $17.6B | $974.7M | ||
| Q4 25 | $17.8B | $10.9B | ||
| Q3 25 | $16.9B | $10.8B | ||
| Q2 25 | $17.8B | $10.6B | ||
| Q1 25 | $17.1B | $10.4B | ||
| Q4 24 | $16.4B | $10.3B | ||
| Q3 24 | $15.6B | $10.2B | ||
| Q2 24 | $14.7B | $9.9B |
| Q1 26 | $20.1B | $14.4B | ||
| Q4 25 | $20.5B | $14.3B | ||
| Q3 25 | $19.4B | $14.7B | ||
| Q2 25 | $20.2B | $14.3B | ||
| Q1 25 | $19.2B | $14.0B | ||
| Q4 24 | $18.7B | $13.5B | ||
| Q3 24 | $17.7B | $13.7B | ||
| Q2 24 | $16.6B | $13.1B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ISRG
| Instruments and accessories | $1.7B | 61% |
| Systems | $650.7M | 23% |
| Services | $433.7M | 16% |
TROW
| Equity | $974.7M | 52% |
| Multi-asset | $509.1M | 27% |
| Administrative, distribution, servicing, and other fees | $138.4M | 7% |
| Fixed income, including money market | $111.8M | 6% |
| Alternatives | $87.4M | 5% |
| Capital allocation-based income (1) | $28.1M | 2% |
| Performance-based advisory fees | $7.5M | 0% |
